← All trials
NCT03092648
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2017
- Primary completion
- Dec 30, 2018
- Completion date
- Feb 28, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Southern Medical UniversityLead sponsor
- Southern Medical UniversityReponsible party - principal investigator
- Regend TherapeuticsCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Regend TherapeuticsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.